NAD+ · Research brief

Endurance Athletes NAD+ Protocol — Performance Science

Real Peptides Research TeamEditorial

Updated July 10, 202610 min read

57 WORDS

Short answer

Key takeaways

NAD+ depletion during prolonged aerobic exercise (above 60% VO2 max for longer than 60 minutes) occurs because NAD+ consumption outpaces cellular regeneration capacity, creating a mitochondrial efficiency bottleneck independent of substrate availability.
Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are direct NAD+ precursors that bypass the rate-limiting salvage pathway enzyme NAMPT, allowing NAD+ replenishment during high metabolic demand when standard niacin supplementation becomes ineffective.
The endurance athletes NAD+ protocol doses at 500–1000mg daily, split into pre-training (60–90 minutes before) and post-training (within 2 hours after) windows to saturate NAD+ pools before depletion and accelerate replenishment during the 48–72 hour recovery window.
Clinical evidence shows 1000mg NMN daily improved aerobic capacity by 11.3% and increased skeletal muscle NAD+ by 60% in active adults, with the effect most pronounced during sustained threshold efforts where mitochondrial NAD+ availability becomes rate-limiting.
Baseline maintenance protocols (250–500mg daily) suffice for recreational athletes training 3–4 days per week at moderate intensity; higher split-dose protocols target competitive athletes with frequent threshold sessions or insufficient recovery windows between training blocks.

A 2023 metabolomics study published in Cell Metabolism found that marathon runners showed 47% reduced skeletal muscle NAD+ levels immediately post-race compared to baseline. A depletion that persisted for 72 hours despite normal caloric and macronutrient intake. That drop wasn't just a biomarker curiosity. NAD+ (nicotinamide adenine dinucleotide) functions as the central electron carrier in mitochondrial respiration. The process that converts stored fuel into usable ATP during aerobic exercise. When NAD+ availability becomes rate-limiting, your mitochondria can't process glucose or fatty acids efficiently no matter how well-fueled you are.

Our team works with research-grade peptides and bioactive compounds used in performance and metabolic research. The gap between supplementing randomly and building a protocol that targets the specific metabolic stressors of endurance training comes down to understanding NAD+ kinetics under sustained aerobic load. Not just taking a trendy longevity supplement because a podcast mentioned it.

What is the NAD+ protocol for endurance athletes?

The endurance athletes NAD+ protocol involves daily supplementation with 300–1000mg of nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN). Both direct NAD+ precursors. Timed around training blocks to support mitochondrial ATP production, reduce oxidative stress accumulation, and accelerate post-exercise NAD+ replenishment. The protocol targets the specific depletion pattern caused by prolonged aerobic exertion, which differs mechanistically from the slower age-related NAD+ decline most longevity protocols address.

Most endurance supplement protocols focus on substrate availability. Carbohydrates for glycogen, electrolytes for hydration, protein for repair. That's not wrong, but it misses the coenzyme layer. NAD+ isn't an energy substrate itself. It's the shuttle that moves electrons through the electron transport chain in your mitochondria. When NAD+ drops during a three-hour training ride or a 20-mile run, your cells lose the capacity to efficiently convert stored energy into ATP even if glycogen and oxygen are abundant. This article covers the specific dosing strategies that align with endurance training stimulus, the timing windows that matter for replenishment, and the mechanistic differences between NAD+ precursors that most athletes don't understand.

NAD+ Depletion Mechanics During Endurance Exercise

NAD+ exists in two forms in cells: NAD+ (oxidised) and NADH (reduced). During aerobic metabolism, NAD+ accepts electrons from glucose or fatty acid breakdown and becomes NADH. NADH then delivers those electrons to Complex I of the electron transport chain, where they drive ATP synthesis. After electron transfer, NADH is oxidised back to NAD+. Completing the cycle. This regeneration happens continuously during low-to-moderate intensity exercise. The system breaks down during prolonged high-intensity aerobic work because NAD+ regeneration can't keep pace with consumption rate.

A 2022 study in The Journal of Physiology measured real-time NAD+/NADH ratios in skeletal muscle during incremental cycling tests. At 60% VO2 max (sustainable aerobic pace), the NAD+/NADH ratio remained stable at approximately 3.8:1. Regeneration matched consumption. At 85% VO2 max (threshold pace), the ratio dropped to 1.9:1 within 45 minutes and continued declining throughout sustained effort. The drop wasn't due to insufficient oxygen delivery. Lactate accumulation and oxidative stress during high-intensity aerobic work consume NAD+ faster through compensatory metabolic pathways (specifically, NAD+ is consumed by enzymes like PARPs and sirtuins that respond to cellular stress signals). Recovery back to baseline NAD+ levels took 48–72 hours without intervention.

Our experience with metabolic research compounds shows that athletes training at threshold or above for extended durations. Tempo runs, long sustained climbs, race-pace intervals. Deplete NAD+ chronically if training frequency doesn't allow full replenishment between sessions. This isn't acute glycogen depletion you feel immediately. It's a gradual erosion of mitochondrial efficiency that manifests as training stagnation, prolonged recovery windows, and diminished power output at previously sustainable paces.

Direct NAD+ Precursors: NR vs NMN for Athletic Application

The two primary NAD+ precursors used in endurance athletes NAD+ protocol design are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both bypass the rate-limiting step of the salvage pathway. The enzyme NAMPT, which converts nicotinamide back to NAD+ and becomes saturated during high metabolic demand. NR is phosphorylated to NMN inside cells, then converted to NAD+. NMN is one enzymatic step closer to NAD+ and may have faster tissue uptake in skeletal muscle, though clinical evidence remains mixed on whether this translates to superior performance outcomes.

A 2021 randomised controlled trial published in Science compared 1000mg NMN daily vs placebo in recreationally active adults over 10 weeks. The NMN group showed 11.3% improvement in aerobic capacity (measured as VO2 max during incremental treadmill test) and significantly higher blood NAD+ levels post-supplementation. Muscle biopsy data revealed increased mitochondrial enzyme activity. Specifically, elevated expression of PGC-1α, the master regulator of mitochondrial biogenesis. NR has similar evidence: a 2019 study in Nature Communications found that 1000mg NR twice daily for 21 days increased skeletal muscle NAD+ by 60% and improved markers of mitochondrial function in middle-aged adults.

The practical difference for athletes: NMN may raise blood NAD+ levels faster due to direct cellular uptake via the Slc12a8 transporter identified in 2019, whereas NR must enter cells and undergo phosphorylation first. For pre-training loading or acute replenishment windows, NMN's faster kinetics could matter. For daily baseline maintenance, both precursors produce comparable steady-state NAD+ elevation when dosed consistently. Cost and availability often dictate choice. NR has broader third-party testing and longer supplement market presence; NMN research is newer but growing rapidly. Real Peptides focuses on research-grade compounds synthesised under controlled conditions. Purity and exact amino-acid sequencing matter when you're targeting specific metabolic pathways.

Dosing Strategy and Timing Windows for Endurance Training

Standard longevity NAD+ protocols recommend 250–500mg NR or NMN once daily, typically in the morning. That dosing works for age-related NAD+ decline but underserves the acute depletion pattern athletes experience. The endurance athletes NAD+ protocol requires higher doses and strategic timing around training stimulus. Research supports 500–1000mg daily for active individuals, split into pre-training and post-training windows when NAD+ demand and replenishment needs peak.

Pre-training dosing (60–90 minutes before sessions longer than 90 minutes or at threshold intensity): 300–500mg NMN or NR. The goal is to saturate tissue NAD+ pools before exercise-induced depletion begins. A 2020 study in Frontiers in Physiology found that pre-exercise NMN administration (500mg) increased time to exhaustion by 8.7% during high-intensity cycling vs placebo. Suggesting elevated baseline NAD+ delays the point at which mitochondrial efficiency collapses under sustained aerobic load. Post-training dosing (within 2 hours post-exercise): 300–500mg NMN or NR. This targets the 48–72 hour replenishment window. NAD+ biosynthesis enzymes (NMNAT and NAMPT) are upregulated post-exercise as part of the adaptive response. Providing substrate during this window accelerates recovery back to baseline levels.

Daily baseline dosing (rest days or easy training days): 250–500mg once daily. Maintains steady-state NAD+ without acute loading. Athletes training 5–6 days per week at mixed intensities should dose daily. Chronic depletion accumulates across training blocks even if individual sessions feel manageable. Testing NAD+ levels directly isn't practical for most athletes (requires blood draw and specialised assay), but subjective markers align well: sustained power output at familiar paces, recovery quality between hard sessions, and absence of unexplained fatigue despite adequate sleep and nutrition all improve when NAD+ isn't chronically depleted.

Endurance Athletes NAD+ Protocol: Dosing Comparison

Protocol Type	Daily Dose	Timing Strategy	Target Athlete Profile	Expected Outcome	Professional Assessment
Baseline Maintenance	250–500mg NR or NMN	Once daily, morning or pre-training	Recreational endurance athletes training 3–4 days/week at moderate intensity	Prevents chronic NAD+ decline from regular training stimulus; maintains mitochondrial baseline function	Sufficient for athletes without frequent high-intensity blocks. Cost-effective and evidence-supported for general metabolic health
Performance Loading (Split Dose)	500–1000mg NR or NMN	300–500mg pre-training (60–90 min before), 300–500mg post-training (within 2 hours)	Competitive athletes training 5–7 days/week with regular threshold or race-pace sessions	Saturates NAD+ pools before depletion, accelerates post-exercise replenishment, supports sustained power output across training blocks	The protocol most aligned with endurance-specific NAD+ depletion patterns. Requires discipline and higher cost but targets the metabolic bottleneck most athletes miss
Acute Race Prep	1000mg NMN (single dose)	90–120 minutes pre-race	Athletes competing in events longer than 2 hours (marathons, century rides, ultramarathons)	Maximises pre-event NAD+ availability to delay mitochondrial efficiency collapse during prolonged high-intensity effort	Experimental but mechanistically sound. Limited clinical evidence for single-dose ergogenic effect, but low risk and potentially meaningful for key competitive events
Recovery Focus (Post-Event)	500mg NR or NMN twice daily	Morning and evening for 5–7 days post-race	Athletes recovering from high-volume or high-intensity competition	Accelerates NAD+ replenishment during the post-race recovery window when mitochondrial repair and adaptation occur	Strong rationale for multi-day loading after major events. NAD+ is consumed heavily during recovery processes (PARP activation, immune response, cellular repair)

What If: Endurance Athletes NAD+ Protocol Scenarios

What If I'm Already Taking a Multivitamin — Does That Cover NAD+ Precursors?

No. Standard multivitamins contain niacin (vitamin B3) or nicotinamide, which are NAD+ precursors but follow a different metabolic pathway. Nicotinamide converts to NAD+ through the salvage pathway, which is rate-limited by the enzyme NAMPT. During high metabolic demand (endurance training), NAMPT becomes saturated. Meaning additional nicotinamide doesn't meaningfully raise NAD+ levels. NR and NMN bypass this bottleneck by entering cells directly and converting to NAD+ through enzymes that aren't rate-limiting. A 100mg niacin dose in a multivitamin provides baseline vitamin sufficiency but won't address exercise-induced NAD+ depletion the way 500mg NMN does.

What If I Don't Notice Any Immediate Performance Change After Starting Supplementation?

NAD+ protocols don't produce acute ergogenic effects like caffeine or beta-alanine. The benefit is cumulative and becomes apparent across training blocks. Sustained power at threshold, faster recovery between hard sessions, and maintained training quality late in multi-week build phases. If you're testing it during a single workout, you won't feel a difference. Most athletes notice measurable changes (subjective and objective) after 3–4 weeks of consistent dosing when NAD+ levels stabilise and mitochondrial adaptations compound. Track metrics like average power during threshold intervals or perceived recovery quality between sessions. Those are where NAD+ sufficiency shows up, not in maximum sprint power or single-effort tests.

What If I Miss Doses During a Training Block — Does That Negate the Protocol?

Missing occasional doses won't negate benefits, but inconsistent dosing prevents NAD+ levels from stabilising. NAD+ has a relatively short half-life in tissue (hours, not days), meaning daily supplementation is necessary to maintain elevated levels. If you miss 2–3 days, tissue NAD+ drops back toward baseline. You're not losing prior adaptations, but you're not maintaining the elevated state either. For athletes mid-training block, prioritise post-training doses over pre-training doses if choosing one. Replenishment matters more than acute loading when training frequency is high.

The Uncomfortable Truth About NAD+ and Athletic Longevity

Here's the honest answer: NAD+ supplementation won't turn a mediocre training plan into a great one, and it won't overcome poor recovery habits or inadequate fuelling. The endurance athletes NAD+ protocol works because it targets a real metabolic constraint. But only when the rest of the system is functioning. We've seen athletes layer NAD+ supplementation onto chronically under-recovered training blocks or caloric deficits and wonder why performance doesn't improve. NAD+ supports mitochondrial efficiency, but it doesn't create energy or replace sleep. The protocol amplifies good training. It doesn't compensate for bad training.

The second uncomfortable truth: most recreational athletes probably don't need 1000mg daily split-dose protocols. If you're training 3–4 days per week at moderate intensity with full recovery between sessions, baseline maintenance dosing (250–500mg daily) is sufficient. The higher-dose performance loading protocols matter for athletes pushing threshold regularly, racing competitively, or training at volumes where recovery windows don't allow full NAD+ replenishment between sessions. Supplement marketing wants you to believe everyone needs maximum doses all the time. The evidence doesn't support that. Match the protocol to your actual training stimulus and metabolic demand, not to what elite athletes do.

The protocol works best when training, recovery, and fuelling are dialed in. NAD+ supplementation amplifies mitochondrial efficiency but doesn't replace foundational endurance physiology. If you're building a performance stack around metabolic optimisation, the compounds you choose matter as much as the dosing strategy. Explore high-purity research peptides designed for precision research applications. Exact synthesis and verified purity are non-negotiable when you're targeting specific cellular pathways under load.

The real question isn't whether NAD+ matters for endurance performance. The metabolomics data and clinical trials make that clear. The question is whether your current training stimulus creates sufficient NAD+ demand to justify intervention, and whether the rest of your recovery and fuelling practices support the adaptation you're trying to unlock. NAD+ protocols close a metabolic gap, but only if that gap exists in the first place.

References

Peer-reviewed sources on NAD+ indexed in PubMed, listed for research context. Real Peptides supplies NAD+ for laboratory research use only.

NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing research reviews, 2026. PMID 41655607. doi:10.1016/j.arr.2026.103057
NAD(+) restores proteostasis through splicing-dependent autophagy. Autophagy, 2026. PMID 41313318. doi:10.1080/15548627.2025.2596679
Endothelial NAD(+) depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. PMID 42033099. doi:10.1002/alz.71423
NAD+ and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations. JCI insight, 2026. PMID 41574612. doi:10.1172/jci.insight.181812
NAD(+) depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside. Journal of neuroinflammation, 2025. PMID 41299539. doi:10.1186/s12974-025-03638-6
Lactate dehydrogenase A-coupled NAD(+) regeneration is critical for acute myeloid leukemia cell survival. Cancer & metabolism, 2025. PMID 40390151. doi:10.1186/s40170-025-00392-4
FOXO1-NMNAT3 axis dysregulation promotes doxorubicin cardiotoxicity: NAD(+) replenishment as a redox-targeted antioxidant therapy. Redox report : communications in free radical research, 2025. PMID 41021886. doi:10.1080/13510002.2025.2565033
NAD+ prevents chronic kidney disease by activating renal tubular metabolism. JCI insight, 2025. PMID 40059824. doi:10.1172/jci.insight.181443

Questions

Most athletes notice subjective improvements in recovery quality and sustained power output after 3–4 weeks of consistent dosing at 500–1000mg daily. Clinical trials measuring aerobic capacity improvements (VO2 max, time to exhaustion) show statistically significant changes at 6–10 weeks. The effect is cumulative rather than acute — NAD+ supplementation raises baseline mitochondrial efficiency across training blocks, which manifests as better performance during threshold efforts and faster recovery between hard sessions rather than immediate ergogenic boost during single workouts.

Yes — NAD+ precursors (NR, NMN) have no known contraindications with standard endurance supplements like creatine, beta-alanine, caffeine, or electrolytes. They work through a distinct metabolic pathway (mitochondrial electron transport) rather than competing for absorption or receptor sites. One consideration: niacin (vitamin B3) at high doses can cause flushing and may interact with NAD+ kinetics, but the doses in multivitamins are too low to matter. If you’re using prescription medications (especially those affecting liver metabolism), consult your prescribing physician before adding NAD+ precursors at doses above 500mg daily.

Both nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are direct NAD+ precursors that bypass the rate-limiting salvage pathway enzyme NAMPT. NMN is one enzymatic step closer to NAD+ and may have faster tissue uptake via the Slc12a8 transporter, making it theoretically better for acute pre-training loading. NR requires phosphorylation to NMN inside cells before NAD+ conversion but has broader third-party testing and longer supplement market presence. For daily baseline maintenance, both produce comparable steady-state NAD+ elevation when dosed consistently — choose based on availability, cost, and individual tolerance.

Yes — post-event NAD+ depletion is substantial and prolonged. A 2023 Cell Metabolism study found marathon runners showed 47% reduced skeletal muscle NAD+ levels immediately post-race, with depletion persisting for 72 hours. High-dose protocols (500mg twice daily for 5–7 days post-event) target the recovery window when NAD+ is consumed heavily by cellular repair processes (PARP activation, immune response, mitochondrial biogenesis). This accelerates return to baseline metabolic function and supports the adaptive response to training stimulus rather than just clearing acute fatigue.

NR and NMN are generally well-tolerated at doses up to 1000mg daily in clinical trials. The most commonly reported side effect is mild gastrointestinal discomfort (nausea, bloating) in approximately 5–10% of users, typically during the first week of supplementation and resolving with continued use. Unlike niacin, NR and NMN do not cause flushing at standard doses. There are no documented serious adverse events in published trials, though long-term safety data (beyond 12 weeks) remains limited. Athletes with pre-existing liver or kidney conditions should consult a healthcare provider before high-dose supplementation.

NAD+ protocols target mitochondrial ATP production during aerobic metabolism — the primary energy system for efforts lasting longer than 2–3 minutes. Sprint and power athletes rely predominantly on phosphocreatine and glycolytic pathways, which don’t depend on NAD+ availability the same way sustained aerobic efforts do. That doesn’t mean NAD+ is irrelevant — it supports recovery and overall metabolic health — but the performance benefit is most pronounced in athletes performing prolonged high-intensity aerobic work (threshold runs, long climbs, time trials, races longer than 30 minutes).

Age-related NAD+ decline is a slow, chronic reduction in baseline tissue NAD+ levels (approximately 50% decline from age 40 to 80) driven by decreased biosynthesis enzyme expression and increased consumption by DNA repair enzymes. Exercise-induced NAD+ depletion is acute and cyclical — tissue levels drop 40–50% during prolonged threshold efforts, then recover over 48–72 hours with adequate rest. Athletes experience both: chronic training stress can lower baseline NAD+ if recovery windows don’t allow full replenishment, compounding the depletion that occurs during individual sessions. Longevity NAD+ protocols target the slow decline; endurance athlete protocols target the acute depletion and inadequate replenishment cycle.

Direct NAD+ measurement requires blood draw and specialised assay (HPLC or mass spectrometry) not available through standard labs — it’s research-tool expensive and impractical for routine monitoring. Indirect markers work better for athletes: sustained power output at familiar paces, perceived recovery quality between sessions, resting heart rate trends, and training consistency without unexplained fatigue all correlate with adequate NAD+ status. If those metrics improve after 3–4 weeks of consistent supplementation at 500–1000mg daily, your protocol is likely working regardless of whether you have lab confirmation.

Current evidence doesn’t suggest cycling is necessary — NAD+ precursors support a fundamental metabolic process rather than manipulating a specific receptor or pathway that downregulates with chronic use. Athletes training year-round can dose continuously, adjusting intake based on training volume and intensity (higher doses during build phases, baseline maintenance during off-season). If cost or tolerance is a concern, prioritise supplementation during high-volume training blocks and competitive phases when NAD+ depletion is most pronounced, then reduce or pause during true off-season when training load drops significantly.

Athletes training twice daily face compounded NAD+ depletion without full replenishment between sessions. The protocol: 300–500mg NMN or NR 60–90 minutes before the first session, then 300–500mg immediately after the second session (total 600–1000mg daily). This saturates NAD+ pools before the first depletion event and prioritises replenishment after the cumulative metabolic stress of both sessions. On rest days, maintain 250–500mg once daily to prevent baseline NAD+ from dropping across the training week. Two-a-day athletes are the population most likely to benefit from split-dose protocols because recovery windows are insufficient for natural NAD+ regeneration between sessions.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA